What is The Emerald?
The Emerald Corp. operates as a comprehensive manufacturer and distributor within the alternative health products sector, specializing in both branded and private-label goods. With over a decade of experience navigating complex and emerging markets, the company's core expertise lies in the formulation and production of supplements, including ingestible and topical formats. Since its entry into the natural supplement market in 2018 with CBD-infused products, The Emerald has strategically diversified into other natural product verticals, driven by a robust R&D team led by head chemist Dr. Talha Parveez, Ph.D. This innovation has resulted in over 200 unique formulations, contributing to substantial sales increases in 2021 and opening new avenues for expansion.
How much funding has The Emerald raised?
The Emerald has raised a total of $4M across 2 funding rounds:
Debt
$2M
Unspecified
$2M
Debt (2022): $2M, investors not publicly disclosed
Unspecified (2022): $2M, investors not publicly disclosed
What's next for The Emerald?
The recent major strategic investment positions The Emerald for accelerated growth and market penetration. This capital infusion is expected to fuel further product development, enhance manufacturing capabilities, and expand distribution networks. The company's established expertise in formulation and its adaptability to evolving market regulations suggest a strong capacity to capitalize on emerging trends in the natural products industry. Future endeavors will likely focus on solidifying its market share and exploring new product categories, leveraging its scientific foundation and decade-long market experience to drive sustained enterprise-level expansion.
See full The Emerald company page
